|
News Mylan Launches First Generic Version of Teveten Tablets
Mylan announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base). |
|
Leaflet Drug Teveten
Description: Eprosartan belongs to the class of medicines called angiotensin II inhibitors. |
|
Leaflet Drug Eprosartan (Oral Route)
Description: Eprosartan belongs to the class of medicines called angiotensin II inhibitors. |